About Nikkei article use service
If you would like to share articles in a company, reprint, copy, and print order, please see the link.
詳しくはこちらOn Tuesday, Shiono has stated on Tuesday that it will set up a supply system for more than 1 million people in 2021 for the new Coronavirus drinks under development.We will also consider applications within the year of the special "conditional early approval" provided by the government in the development of new drugs, and prepare for early supply after approval.If you can use a medicine that you can take at home that you can take at home, it has the advantage of avoiding the tightness of the medical system.
【Related article】
On the 5th, the number of home medical treatments has increased rapidly, as the number of new Corona infected in Tokyo has exceeded 5,000, and the number of infections has not expanded nationwide.Currently, there are four new Corona treatments approved in Japan, but only for mildly illnesses is the antibody cocktail therapy for Chugai Pharmaceuticals.The need for drinks that can be easily taken at home is large, and the Japanese corporation MSD in Merck is also developing.
Yoshiyoshi Shioni's treatment hinders the function of enzymes necessary for the growth of the virus.Assuming how to use it once a day for 5 days.It is administered in the early stages of infection to suppress severe illness and improve symptoms such as fever and cough.
Yoshiyoshi Shiono started a first -stage clinical trial (clinical trial) in Japan in July.He administers 75 healthy adults under the age of 20 and 55 to examine safety.Depending on the results of the clinical trial, we will consider applying for approval within the year while conducting large -scale clinical trials in the final stage.We have begun discussions with the US Ministry of Health and Welfare with a view to supply overseas.
Yoshiyoshi Shiono is also developing a new colona vaccine.The final stage clinical trial will be started this year in either comparison with other companies' vaccines or comparison with a placebo, and we aim to put it into practical use until the end of March 2010.The company plans to establish a production system for up to 60 million people a year at a factory in Gifu Prefecture, a partner.
【Related article】
アプリで開くAll articles are read and the unlimited paid members are free for the first month
About Nikkei article use service
If you would like to share articles in a company, reprint, copy, and print order, please see the link.
詳しくはこちらRelated Links
You can read the new colon virus here.Vaccine / therapeutic drug relief / compensation business Domestic overseas infection status
Following the topic will make it easier to check and read new information.
Related article
Related companies and industries
企業：Related keywords